老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Processa Pharmaceuticals, Inc.

2.01
-0.0700-3.37%
成交量：9,844
成交額：1.96萬
市值：561.47萬
市盈率：-0.36
高：2.11
開：1.97
低：1.95
收：2.08
52周最高：14.24
52周最低：1.67
股本：279.34萬
流通股本：252.39萬
量比：0.39
換手率：0.39%
股息：- -
股息率：- -
每股收益(TTM):-5.5949
每股收益(LYR):-96.8176
淨資產收益率：-464.20%
總資產收益率：-156.79%
市淨率：-17.69
市盈率(LYR):-0.02

資料載入中...

總覽公司新聞資訊公告
2021/04/07

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/25

重要事件披露

8-K - Current report
2021/03/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/18

重要事件披露

8-K - Current report
2021/01/11

重要事件披露

8-K - Current report
2020/11/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/05

重要事件披露

8-K - Current report
2020/10/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/13

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/10/13

重要事件披露

8-K - Current report
2020/10/06

重要事件披露

8-K - Current report
2020/09/30

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/29

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/29

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/25

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/22

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/22

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/17

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/08/27

重要事件披露

8-K - Current report
2020/08/20

重要事件披露

8-K - Current report
更多